['lizbeth]

GDP and mjm,

My logic is the more drugs approved by participation in the current system, the more options we will have when the randomized clinical trial system is abandoned.

Yet there is small progess with testing for CLL. How did this happen? Instead of a study like I-SPY that is still randomized, how do we get a study with CRSA for breast cancer?

Is the better question who can get this done, and not how? Who has the influence?

We have discussed this back and forth, we have posted our frustrations.

Is it time for us to start a non profit to get the message out to patients and fund CRSA for breast cancer?